Results 121 to 130 of about 15,613 (254)

Paroxysmal nocturnal hemoglobinuria: a singleSpanish center's experience over the last 40 yr [PDF]

, 2014
Cristina Muñoz‐Linares, Emilio Ojeda, Rafael Forés, Miguel Pastrana, Martín Cabero, Daniel Morillo, Guiomar Bautista, I. Baños, C. Monteserín, Pilar Bravo, Esther Jaro, María‐Teresa Cedena, Juan Luis Steegmann, Ana Villegas, José Rafael Cabrera   +14 more
openalex   +1 more source

Antiphosphatidylserine antibody as a cause of multiple dural venous sinus thromboses and ST-elevation myocardial infarction [PDF]

, 2018
Objective: Rare disease Background: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by antibodies directed against phos-pholipids on plasma membranes. Through unclear mechanisms, APS confers hypercoagulability.
Marquardt, Caillin W., Pickens, Peter V., Varner, Chelsea K.   +2 more
core   +1 more source

PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL

, 2023
Antonio M. Risitano, David J. Araten, David J. Kuter, Bhumika J. Patel, Régis Peffault de Latour, Marion Dahlke, Tania Garito, Shujie LI, Samopriyo Maitra, Austin Kulasekararaj   +9 more
openalex   +1 more source

Successful haploidentical hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with severe pancytopenia developed after long‐term aplastic anemia treatment

Clinical Case Reports
Key Clinical Message Haploidentical hematopoietic stem cell transplantation (HSCT) with posttransplant cyclophosphamide is an alternative treatment for aplastic anemia–paroxysmal nocturnal hemoglobinuria (PNH) syndrome with poor prognostic factors ...
Kazuki Sakurai, Kei Saito, Shunsuke Hatta, Yuna Katsuoka, Kuniaki Meguro, Hisayuki Yokoyama, Toru Izumi   +6 more
doaj   +1 more source

Paroxysmal nocturnal hemoglobinuria--hemolysis before and after eculizumab. [PDF]

, 2010
Hill A, Hillmen P., Kelly R, Luzzatto L, Notaro R, RISITANO, ANTONIO MARIA   +5 more
core   +1 more source

Markedly high population of affected reticulocytes negative for decay- accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria [PDF]

, 1995
Norihiro Iwamoto, T Kawaguchi, Shoichi Nagakura, Masumi Hidaka, K Horikawa, Tadashi Kagimoto, K Takatsuki, Hideki Nakakuma   +7 more
openalex   +1 more source

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria [PDF]

, 2007
Peter Hillmen, Petra Muus, Ulrich Dührsen, Antonio M. Risitano, Jörg Schubert, Lucio Luzzatto, Hubert Schrezenmeier, Jeff Szer, Robert A. Brodsky, Anita Hill, Gèrard Socié, Monica Bessler, Scott A. Rollins, Leonard Bell, Russell P. Rother, Neal S. Young   +15 more
openalex   +1 more source

Case Report: Paroxysmal Nocturnal Hemoglobinuria with the Development of Aplastic Anemia [PDF]

, 1953
Mark Nelson, Julian Bruce
openalex   +1 more source

Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia [PDF]

, 2018
Bone marrow transplantation (BMT) and immunosuppression (IS) have improved the prognosis of aplastic anemia; both treatments have specific advantages and drawbacks but similar survival rates.
Favre, Geneviève, Gratwohl, Alois, Gregor, Michael, Kühne, Thomas, Nissen, Catherine, Passweg, Jakob, Tichelli, André, Viollier, Romaine   +7 more
core  

Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience [PDF]

, 2018
Morag Griffin, Austin Kulasekararaj, Sheyans Gandhi, Talha Munir, Stephen J. Richards, Louise Arnold, Nana Benson-Quarm, Nicola Copeland, Isabel Duggins, Kathryn Riley, Peter Hillmen, Judith Marsh, Anita Hill   +12 more
openalex   +1 more source